Cart
sales@molnova.com
Ro-3201195
CAS No. 249937-52-8
Ro-3201195( —— )
Catalog No. M36218 CAS No. 249937-52-8
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 329 | In Stock |
|
| 5MG | 304 | In Stock |
|
| 10MG | 456 | In Stock |
|
| 25MG | 747 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1376 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2753 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRo-3201195
-
NoteResearch use only, not for human use.
-
Brief DescriptionRo-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
-
DescriptionRo-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number249937-52-8
-
Formula Weight371.36
-
Molecular FormulaC19H18FN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC=1N(N=CC1C(=O)C2=CC(OCC(CO)O)=CC=C2)C3=CC=C(F)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Scio-323
Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
-
ZINC05007751
ZINC05007751 is an effective inhibitor of NIMA-related kinase NEK6 (IC50 = 3.4 μM). ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity observed against NEK2, NEK7, and NEK9.
-
HPK1-IN-4
HPK1-IN-4 is an HPK1 (MAPK41) inhibitor with an IC 50 of 0.061 nM. HPK1-IN-4 is often used as a preclinical immunotherapy tool compound.
